Dynamized ethyl alcohol improves immune response and behavior in murine infection with Trypanosoma cruzi

Patrícia F Sandri1, Angela R Portocarrero2, Larissa Ciupa1

  • 1Program in Biosciences and Physiopathology, Universidade Estadual de Maringá (UEM), Av. Colombo 5790, Bloco T20, 87020-900 Maringá, PR, Brazil.

Cytokine
|August 1, 2017
PubMed
Abstract

Insights

Ethylicum 6cH improved survival in mice infected with Trypanosoma cruzi by reducing inflammation and promoting a Th2 immune response. Ethylicum 30cH, however, increased mortality and Th1-associated inflammation.

Area of Science:

  • Homeopathy
  • Immunology
  • Parasitology

Background:

  • Trypanosoma cruzi infection, the causative agent of Chagas disease, poses a significant global health challenge.
  • Current treatments for T. cruzi infection have limitations, necessitating the exploration of alternative therapeutic strategies.
  • Dynamized preparations of ethyl alcohol, such as Ethylicum, are used in homeopathic medicine, but their efficacy against parasitic infections requires rigorous scientific evaluation.

Purpose of the Study:

  • To investigate the effects of two different potencies of dynamized ethyl alcohol (Ethylicum 6cH and 30cH) on acute Trypanosoma cruzi infection in a murine model.
  • To assess the impact of Ethylicum treatment on survival rates, inflammatory markers, cytokine profiles, and behavioral changes in infected mice.

Main Methods:

  • A blind, randomized, and controlled study was conducted using 63 Swiss male mice infected with the T. cruzi Y-strain.
  • Mice were allocated into non-infected, infected non-treated, Ethylicum 6cH-treated, and Ethylicum 30cH-treated groups.
  • Survival, mortality, serum cytokine levels (TNF-α, IL-6, IL-10, IL-5, IL-17A), cardiac inflammation, and behavioral parameters were assessed.

Main Results:

  • Ethylicum 6cH treatment was associated with significantly greater survival, reduced cardiac inflammation, elevated IL-5 and IL-10 levels (indicating a Th2 response), and decreased immobility.
  • Conversely, Ethylicum 30cH treatment correlated with higher mortality, increased cardiac inflammation, and elevated IL-6 and TNF-α levels (indicating a Th1 response).

Conclusions:

  • Ethylicum 6cH demonstrates a beneficial effect in managing acute Trypanosoma cruzi infection in mice.
  • The findings suggest that the therapeutic outcome is potency-dependent, with the 6cH potency showing protective effects while the 30cH potency appeared detrimental.

Related Concept Videos